glutathione synthase Synthetase Deficiency as a Cause of Hereditary Hemolytic Disease glutathione synthetase gene Multiple congenital

WHAT THIS ARTICLE VERIFIED: The evaluation in this article is based on the official ProHealth product page at prohealth.com, the physical Supplement Facts label (REV.04.25), the brand's published FAQ and company background materials, published research cited on the product page, FDA and WADA regulatory documentation publicly available as of May 2026, and a review of competing wire releases in the BPC-157 supplement category

It is widely used in laboratory experiments

Frequently testing active ingredients and finished compounded products via third-party analytical assessment for sterility, potency, and endotoxins

Resolves without intervention in 95% of cases

Importantly, FOXO4-DRI showed no significant toxicity or impact on viability and apoptosis in normal TM3 Leydig cells, where FOXO4 expression is typically low

BPC-157 may have a wide range of therapeutic potentials and speed up the healing process of various tissues in mice, especially connective tissue, thanks to its effects on fibroblasts